Diagnosis and management of pergolide-induced fibrosis (multiple letters) [4]

Movement Disorders

Volumn 20, Issue 4, 2005, Pages 512-513

  Hirani, Naushad ^a   Bayliff, Charles C ^a   McCormack, David G ^a   Frucht, Steven ^b   Agarwal, Pinky ^c   Fahn, Stanley ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NEUROLOGICAL INSTITUTE   (United States)

^c Neurological Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ASBESTOS; ERGOT DERIVATIVE; PERGOLIDE; PREDNISONE;

ASBESTOSIS; CONGESTIVE HEART FAILURE; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; KIDNEY DYSFUNCTION; LETTER; LUNG FIBROSIS; LUNG FUNCTION TEST; OCCUPATIONAL EXPOSURE; PATIENT MONITORING; PLEURAL FIBROSIS; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCREENING TEST; THORAX PAIN; THORAX RADIOGRAPHY; VALVULAR HEART DISEASE;

AGED; ASBESTOSIS; DOPAMINE AGONISTS; FATAL OUTCOME; HUMANS; MALE; MESOTHELIOMA; PERGOLIDE; PLEURAL NEOPLASMS; PULMONARY FIBROSIS; RESTLESS LEGS SYNDROME;

EID: 20344373175     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20443     Document Type: Letter

References (0)